Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Guanylyl cyclase is an enzyme that catalyzes the conversion of guanosine triphosphate (GTP) to cyclic guanosine monophosphate (cGMP), a critical second messenger involved in numerous physiological processes. It exists in two main forms: soluble guanylyl cyclases (sGC), activated by nitric oxide, and membrane-bound/particulate guanylyl cyclases, activated by peptide hormones. cGMP generated via guanylyl cyclase signaling acts as an intracellular second messenger with diverse roles in smooth muscle cells, neurons, kidneys/intestines/retina/bone/cartilage.
Catalyzes the conversion of guanosine triphosphate (GTP) to cyclic guanosine monophosphate (cGMP), a critical second messenger involved in numerous physiological processes. Soluble guanylyl cyclase is activated by nitric oxide binding to its heme group.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Guanylyl Cyclase (GC).